Geraniin Ameliorates Hypertensive Vascular Remodelling in a Diet-Induced Obese Animal Model through Antioxidant and Anti-Inflammatory Effects
Nutrients · 2023
DOI: 10.3390/nu15122696 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Boon Hee Goh und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Science, Monash University Malaysia, Bandar Sunway 47500, Malaysia. Hauptthemen laut MEDLINE: Antioxidants, Hypertension. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Higher Education, Monash University Malaysia, Fundamental Research Grant Scheme (FRGS) of the Ministry of Higher Education (MOHE), Malaysia.
Abstract (Originalsprache)
Geraniin, an ellagitannin, has shown a potent blood pressure-lowering effect in vivo. Therefore, this study aims to further characterize the ability of geraniin to attenuate hypertensive vascular dysfunction, a key feature of cardiovascular disease (CVD) development. Hypertension was induced in male Sprague-Dawley rats through feeding a high-fat diet (HFD) for eight weeks, followed by oral administration of 25 mg/kg/day geraniin for four weeks. The parameters of vascular dysfunction such as the structure and function of blood vessels as well as the vascular oxidative stress and inflammation were evaluated. The outcomes of geraniin-treated rats were compared with those of untreated rats on either a normal diet (ND) or HFD and with HFD-fed rats treated with captopril (40 mg/kg/day). We found that geraniin supplementation effectively ameliorated HFD-induced hypertension and abnormal remodelling of the thoracic aorta by suppressing excessive vascular superoxide (O2−) radical generation and overexpression of pro-inflammatory mediators in the circulating leukocytes. Furthermore, compared to the ND-fed rats, geraniin also independently promoted the significant enlargement of the thoracic aortic lumen for blood pressure reduction. Notably, the vascular benefits of geraniin were comparable to that of captopril. Collectively, these data suggest that geraniin can mitigate hypertensive vascular remodelling caused by overnutrition, which potentially abrogates the further development of CVDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Science, Monash University Malaysia, Bandar Sunway 47500, Malaysia.
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 637551, Singapore.
- Faculty of Medicine, Segi University, Kuala Lumpur 50010, Malaysia.
- School of Pharmacy, University of Nottingham Malaysia Campus, Semenyih 43500, Malaysia.
- Jeffrey Cheah School of Medicine and Health Science, Monash University Malaysia, Subang Jaya 47500, Malaysia.
ORCID-Profile: Boon Hee Goh, Hong Sheng Cheng, Kang-Nee Ting, Uma Devi Palanisamy
Förderung
- Ministry of Higher Education
- Monash University Malaysia
- Fundamental Research Grant Scheme (FRGS) of the Ministry of Higher Education (MOHE), Malaysia
- Tropical Medicine and Biology (TMB) Platform, Monash University Malaysia
Zitieren
APA
Goh, B. H., Cheng, H. S., Alexandra, P. T. A. A., Ting, K. N., Palanisamy, U. D., & Tan, J. B. L. (2023). Geraniin Ameliorates Hypertensive Vascular Remodelling in a Diet-Induced Obese Animal Model through Antioxidant and Anti-Inflammatory Effects. Nutrients. https://doi.org/10.3390/nu15122696
Vancouver
Goh BH, Cheng HS, Alexandra PTAA, Ting KN, Palanisamy UD, Tan JBL. Geraniin Ameliorates Hypertensive Vascular Remodelling in a Diet-Induced Obese Animal Model through Antioxidant and Anti-Inflammatory Effects. Nutrients. 2023. doi:10.3390/nu15122696
BibTeX
@article{Goh2023,
author = {Goh, Boon Hee and Cheng, Hong Sheng and Alexandra, Pricilla Tracy A/P A and Ting, Kang-Nee and Palanisamy, Uma Devi and Tan, Joash Ban Lee},
title = {Geraniin Ameliorates Hypertensive Vascular Remodelling in a Diet-Induced Obese Animal Model through Antioxidant and Anti-Inflammatory Effects},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15122696}
}
EUVIMED